
About PHAROSE REMEDIES
PHAROSE REMEDIES is a Healthcare company based in Jammu (India) founded in 1992. It manufactures quality pharmaceutical products including antibiotics and antivirals for global access. It operates on a B2B model. Its Indian entity Pharose Remedies Limited reported revenue of βΉ115 Cr. PHAROSE REMEDIES offers products and services including Nephrology Products, Antivirals, Antibiotics, Cardiovascular Drugs, and Anti-diabetics. Its focus areas include Pharmaceuticals, Drug Manufacturing, Formulations and Specialty Drugs.
Company details
Pharose Remedies Limited, established in 1998, focuses on producing affordable, high-quality finished pharmaceutical formulations. The company operates from state-of-the-art facilities in Bari Brahamana near Jammu, India, covering categories like nephrology, antivirals, antibiotics, cardiovascular drugs, and more. It aims to enhance healthcare accessibility through manufacturing and distribution, serving clients in the pharmaceutical sector with a commitment to quality and affordability.
- Headquarters Jammu, India
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website pharoseremedies.com
- Legal Name Pharose Remedies Limited
- Date of Incorporation 17 Nov, 1997
- Jurisdiction Punjab, India
- Annual Revenue₹115 Cr
FY 2025 · +4% YoY
- Net Profit₹18.44 Cr
FY 2025 · 16% margin
- EBITDA₹26.25 Cr
FY 2025 · 23% margin
Associated legal entities of PHAROSE REMEDIES
PHAROSE REMEDIES is associated with 2 registered companies on The Company Check; the primary company is Pharose Remedies Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pharose Remedies Limited CIN U24239PB1997PLC020673 | Active | 17 Nov 1997 | ₹115 Cr | 144 | 5 | View details | |
| J And K Waxofield Llp CIN AAS-7358 | Active | 29 Jun 2020 | Jalandhar, Punjab | 2 | View details |
Products & Services of PHAROSE REMEDIES
PHAROSE REMEDIES offers a comprehensive portfolio of products and services, including Nephrology Products, Antivirals, Antibiotics, Cardiovascular Drugs, and Anti-diabetics.
Medicines for treating kidney-related conditions effectively.
Drugs designed to combat viral infections and diseases.
Formulations to fight bacterial infections and related issues.
Medications for managing heart and blood vessel conditions.
Products to control blood sugar levels in diabetic patients.
Board of directors of Pharose Remedies Limited (PHAROSE REMEDIES)
Pharose Remedies Limited is the primary company behind PHAROSE REMEDIES. The boards of the 2 registered companies of PHAROSE REMEDIES currently have 6 directors; the longest-serving is Pardeep Jain, appointed in 1997. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pardeep Jain DIN 00525546 | Managing Director | 18 Nov 1997 | 29 yrs | Pharose Remedies Limited |
| Ram Rai Chandara DIN 02531443 | Whole-time director | 01 Apr 2005 | 21 yrs 7 mo | Pharose Remedies Limited |
| Kanta Jain DIN 00529929 | Designated Partner | 29 Jun 2020 | 6 yrs 4 mo | J And K Waxofield Llp |
| Nand Kishore Jain DIN 00512342 | Designated Partner | 29 Jun 2020 | 6 yrs 4 mo | J And K Waxofield Llp, Pharose Remedies Limited |
| Kirpal Singh DIN 10993757 | Director | 18 Mar 2025 | 1 yr 8 mo | Pharose Remedies Limited |
| Varun Garg DIN 11094999 | Director | 01 Jun 2025 | 1 yr 5 mo | Pharose Remedies Limited |
Financials of PHAROSE REMEDIES
Figures of Pharose Remedies Limited, the primary company behind PHAROSE REMEDIES, for FY 2025. Revenue was ₹115 Cr (+4% year on year). Net profit was ₹18.44 Cr (16% margin). EBITDA was ₹26.25 Cr (23% margin). Revenue has grown at a compounded annual rate of +7% over three years and +23% over five years.
- ₹115 CrRevenue · FY 2025 · +4% YoY
- ₹18.44 CrNet profit · 16% margin
- ₹26.25 CrEBITDA · 23% margin
- ₹2.00 CrPaid-up capital
- 144Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +23%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pharose Remedies Limited are on its company page.
Detailed financial statements for PHAROSE REMEDIES
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PHAROSE REMEDIES
PHAROSE REMEDIES was founded in 1992.
PHAROSE REMEDIES is headquartered in Jammu, India. It is registered at Jammu, Jammu And Kashmir, India.
The primary company behind PHAROSE REMEDIES, Pharose Remedies Limited, reported revenue of βΉ115 Cr for FY 2025, up 4% year on year.
Pharose Remedies Limited, established in 1998, focuses on producing affordable, high-quality finished pharmaceutical formulations. The company operates from state-of-the-art facilities in Bari Brahamana near Jammu, India, covering categories like nephrology, antivirals, antibiotics, cardiovascular drugs, and more. It aims to enhance healthcare accessibility through manufacturing and distribution, serving clients in the pharmaceutical sector with a commitment to quality and affordability.
PHAROSE REMEDIES offers Nephrology Products, Antivirals, Antibiotics, Cardiovascular Drugs, and Anti-diabetics.
PHAROSE REMEDIES is associated with 2 legal entities: Pharose Remedies Limited, J And K Waxofield Llp.
The legal entities of PHAROSE REMEDIES currently have 6 directors, including Kanta Jain, Nand Kishore Jain, Pardeep Jain and others.